Navigation Links
Insmed Completes Sale of Follow-On Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million
Date:3/31/2009

RICHMOND, Va., March 31 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq: INSM), a biopharmaceutical company, announced today that it has successfully closed the sale of all of the Company's assets related to its follow-on biologics business to a subsidiary of Merck & Co., Inc. As a result of this closing, Insmed has now received $130 million, the aggregate purchase price, for the assets. After fees, taxes and other costs related to the transaction, net proceeds are expected to be approximately $123 million.

As a result of the transaction, Merck purchased all rights to Insmed's follow-on biologic assets, including INS-19 and INS-20, as well as control of the Boulder, Colorado-based manufacturing facility. Merck, through an affiliate, has assumed the facility's lease and ownership of all the equipment in the building. In addition, Merck has offered positions to employees of the Boulder facility. Insmed has retained its Richmond, VA corporate office, which houses its Clinical, Regulatory, Finance, and Administrative functions, in support of the continuing IPLEX(TM) program.

Insmed will continue to carefully evaluate potential uses of the proceeds from the transaction.

RBC Capital Markets served as exclusive financial advisor to Insmed on the transaction and the review of strategic alternatives, and provided a fairness opinion to the Company's Board of Directors. McGuire Woods, LLP acted as legal advisor to Insmed and Fried, Frank, Harris, Shriver & Jacobson LLP acted as legal advisor to Merck.

About Insmed

Insmed Inc. is a biopharmaceutical company with unique protein development experience and a proprietary protein platform aimed at niche markets with unmet medical needs. For more information, please visit http:/
'/>"/>

SOURCE Insmed Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Insmed Announces FDA Issues Statement Regarding Position on Allowing Patients With ALS Access to IPLEX(TM) Under an IND
2. Insmed and Premacure Announce European Orphan Designation for IPLEX(TM) in Retinopathy of Prematurity in Infants
3. Insmed Gains Royalty-Free Worldwide Rights for IPLEX(TM) in Connection with Potential Expanded Access ALS Programs
4. Insmed to Present at Upcoming Healthcare Conferences
5. Insmed to Present at the IBC 5th Annual Global Follow-On Biologics Conference
6. Bioniche Completes Recruitment in First Phase III Clinical Trial with Urocidin(TM)
7. Immunotech Completes Merger Acquisition
8. Arcadia Completes New Financing; Previews Fourth Quarter Results
9. Roche Completes Acquisition of Genentech
10. Phyhealth Completes Funding Transaction with AccessKey IP, Inc.
11. Endo Pharmaceuticals Completes Acquisition of Indevus Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/20/2014)... Today, Balfleet.com, one of the most ... offering 50%-70% off on its Mother of the ... mother of the bride dresses from Balfleet.com feature gorgeous ... accessible and takes pride in providing high quality dresses ... offering great discounts on our mother of the bride ...
(Date:12/19/2014)... Tampa, FL (PRWEB) December 19, 2014 ... Celliant Revitalizing Bedsheets are now available. Celliant, the ... in both sheets and pillowcases. , There are ... clinically proven additional circulation, increased oxygenation and balanced ... quality, faster healing and pain relief; enhanced athletic ...
(Date:12/19/2014)... NY (PRWEB) December 20, 2014 These ... Russia, and other nations. Around 151,000 tons of vanadium ... year. The global vanadium usage increased at 6.7% AAGR ... the steel and iron industry, being the largest consumer, ... in 2013, followed by titanium-vanadium alloy and the chemical ...
(Date:12/19/2014)... (HealthDay News) -- The intestinal bacteria that cause inflammatory ... may be inherited, researchers report. The findings, published ... help in efforts to prevent the disease and treat ... study authors added. "The intestinal bacteria, or ,gut ... have a big impact on your health for the ...
(Date:12/19/2014)... FRIDAY, Dec. 19, 2014 (HealthDay News) -- The cost ... patients, well-being, a new study finds. Researchers examined ... had been diagnosed with colorectal or lung cancer. Of ... were cancer-free, and more than 100 had advanced cancer. ... struggling to pay their medical bills, which was linked ...
Breaking Medicine News(10 mins):Health News:Balfleet.com is Offering 50%-70% Off of its Mother of the Bride Dresses 2Health News:Energy Textiles Launches Celliant Revitalizing Bedsheets 2Health News:Marketresearchreports.biz: Global Vanadium Usage Increased at AAGR of 6.7% between 2001 and 2013 2Health News:Marketresearchreports.biz: Global Vanadium Usage Increased at AAGR of 6.7% between 2001 and 2013 3Health News:Crohn's, Colitis May Have Genetic Underpinnings, Study Finds 2Health News:Cancer Treatment Costs Weigh Heavily on Patients, Study Finds 2
... 2009, the congress of the European Association of Cardiovascular ... of a five-year period of heart-healthy political activity in ... of the European Heart Health Charter to the European ... congress joint organiser Professor Joep Perk. "Now is the ...
... WASHINGTON, March 11 On Friday, March 6, ... Department of Justice, the FBI, the FDA, and the Commonwealth ... test. Coast Independent Review Board discovered that a protocol submitted ... Med Systems of Clifton, Virginia, was fraudulent in violation of ...
... Brings 20+ Years of Experience in Complex Rehab IndustryWILKES-BARRE, ... specialist with more than 21 years of experience, has ... of the nation,s fastest growing accredited complex rehab companies. ... and a Certified Rehabilitation Technology Supplier (CRTS) in Wilkes-Barre, ...
... (OTC Bulletin Board: EFSF) announced today that its monthly investor conference ... PM Eastern Time. To participate in the call, please dial 1-877-407-4018 ... at: http://viav i d.net/dce.aspx? ... 0 5 FD1 The conference call will be ...
... -- Orthopaedic surgeon David Teuscher, MD, was elected ... the American Academy of Orthopaedic Surgeons (AAOS) at ... in Las Vegas. He will also serve on the ... one of the voices for our Board of Councilors and ...
... Therapies for Treating Patients With Mutated KRAS Genes ... a New Report from Decision ResourcesWALTHAM, Mass., March ... leading research and advisory firms for pharmaceutical and ... Avastin and Bristol-Myers Squibb/ImClone Systems*/Merck KGaA,s Erbitux will ...
Cached Medicine News:Health News:EuroPRevent 09: Changing hearts and minds in the drive to prevent cardiovascular disease 2Health News:EuroPRevent 09: Changing hearts and minds in the drive to prevent cardiovascular disease 3Health News:Clinical Trial Fraud Exposed by Coast IRB 2Health News:Veteran Rehab Specialist, James Conwell, Joins Fast-Growing Alliance Seating & Mobility in Pennsylvania 2Health News:eFoodSafety.com Announces Investor Conference Call 2Health News:David Teuscher, MD, Elected Secretary of Academy Board of Councilors 2Health News:Use of Avastin and Erbitux in the Adjuvant Setting and Launches of Emerging Agents Will Drive the Colorectal Cancer Drug Market to $7.8 Billion in 2017 2Health News:Use of Avastin and Erbitux in the Adjuvant Setting and Launches of Emerging Agents Will Drive the Colorectal Cancer Drug Market to $7.8 Billion in 2017 3
(Date:12/19/2014)... SAN DIEGO , Dec. 18, 2014  RESMED INC. ... report its second quarter of fiscal year 2015 results on ... market close. A press release with ResMed,s results will be ... will host a webcast to discuss operating results and future ... at 1:30 p.m. US Pacific Time and the live webcast ...
(Date:12/19/2014)... , Dec. 19, 2014  Eli Lilly and ... Paris: FR0011184241 – ADOC) today announced a worldwide licensing ... BioChaperone Lispro, for treatment in people with type 1 ... proprietary BioChaperone® technology and is currently in Phase Ib ... Lispro with the goal of optimizing glucose levels during ...
(Date:12/17/2014)... Revenue and earnings above the previous year - ... In the past 2013/14 fiscal year (ended 30 September ... 4.287 billion (last year: EUR 4.190 billion) despite unfavorable currency ... million. "Overall, 2013/14 was a successful fiscal year for the ... CEO of Carl Zeiss AG. "Thanks to our broad portfolio ...
Breaking Medicine Technology:ResMed To Announce Second Quarter 2015 Results 2Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 2Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 3ZEISS Asserts its Position in Difficult Environment 2
... Holdings, Inc. ("Bacterin") (OTC Bulletin Board: BIHI ... announced that it launched its OsteoSponge®SC product at the ... taking place February 15-19 in San Diego, CA.  Based ... the Food and Drug Administration to market OsteoSponge®SC as ...
... Feb. 16, 2011 MedAptus®, the market leader ... England Baptist Hospital (NEBH) has selected the company,s ... medicine providers. The NEBH hospitalist team, comprised of ... Inpatient Edition via the web as well as ...
Cached Medicine Technology:Bacterin International to Announce Launch of OsteoSponge®SC at American Academy of Orthopedic Surgeons 2011 Annual Meeting February 15-19 2Bacterin International to Announce Launch of OsteoSponge®SC at American Academy of Orthopedic Surgeons 2011 Annual Meeting February 15-19 3Hospitalists at New England Baptist Hospital Choose MedAptus 2
Straight shafts with teeth and 5 mm tying platform. Wide serrated handle with polished finish. Teeth: 0.3 mm. Manufactured in titanium....
Ergotec Vetriretinal Instrument System. Extra fine angled tips (3 mm). 20 ga. shaft tapering to 23 ga., 10 mm from tip. Overall length from rear rotation knob to tip....
Ergotec Vetriretinal Instrument System. 2 mm pointed black tips with 0.6 mm platform. 20 gauge shaft tapers to 23 gauge....
Ergotec Vetriretinal Instrument System. Ultra-fine 0.8 mm tips. Angled 40 degrees. 20 gauge shaft tapers to 23 gauge....
Medicine Products: